| human | Q5 |
| P6178 | Dimensions author ID | 01114651121.45 |
| P11720 | IRInSubria author ID | 21588 |
| P11718 | OPENBS author ID | 94868 |
| P496 | ORCID iD | 0000-0001-6298-4111 |
| P3829 | Publons author ID | 2575589 |
| P1053 | ResearcherID | O-3119-2013 |
| P1153 | Scopus author ID | 57201663260 |
| 7005103817 |
| P108 | employer | National Cancer Institute | Q3747179 |
| P734 | family name | Radice | Q25114577 |
| Radice | Q25114577 | ||
| Radice | Q25114577 | ||
| P735 | given name | Paolo | Q15731774 |
| Paolo | Q15731774 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q51569689 | A BRCA1 promoter variant (rs11655505) and breast cancer risk. |
| Q61763441 | A Panel of Sequence Tagged Sites for Chromosome Band 11q23 |
| Q36511037 | A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity |
| Q40230514 | A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q53482353 | A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. |
| Q36152991 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers |
| Q77344066 | A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation |
| Q61970270 | A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor |
| Q24290116 | A novel zinc finger gene is fused to EWS in small round cell tumor |
| Q47233826 | A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy |
| Q55560455 | A predictive model of metachronous colorectal cancer occurrence in Lynch syndrome. |
| Q53355540 | A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project. |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q58813393 | APC Genotype Is Not a Prognostic Factor in Familial Adenomatous Polyposis Patients With Colorectal Cancer |
| Q53238843 | Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. |
| Q58813492 | Allelotyping in Wilms Tumors Identifies a Putative Third Tumor Suppressor Gene on Chromosome 11 |
| Q36882665 | An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
| Q58813314 | An unusual BRCA2 allele carrying two splice site mutations |
| Q37193409 | Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1 |
| Q51540667 | Analysis of gene copy number variations using a method based on lab-on-a-chip technology. |
| Q104101500 | Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse |
| Q55479705 | Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. |
| Q40351590 | Androgen receptor CAG repeat length and estrogen receptor status in postmenopausal breast cancer prognosis |
| Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q37499529 | Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study |
| Q91271723 | Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness |
| Q51102259 | Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy. |
| Q36178189 | Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q44567135 | Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy. |
| Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35523236 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q61970278 | Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers |
| Q24531993 | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies |
| Q62712290 | BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding |
| Q61970272 | BRCA1p.Val1688del Is a Deleterious Mutation That Recurs in Breast and Ovarian Cancer Families From Northeast Italy |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q40554783 | BglII polymorphism of the epidermal growth factor receptor (EGF-R) gene |
| Q54677732 | Bilateral preaxial polydactyly in a WAGR syndrome patient. |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q114182645 | Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores |
| Q43073201 | Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q57305977 | Breast-Cancer Risk in Families With Mutations in PALB2 |
| Q34148873 | Breast-cancer risk in families with mutations in PALB2 |
| Q33630773 | COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. |
| Q36998293 | COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration |
| Q92005489 | Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families |
| Q34963894 | Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q38931772 | Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus |
| Q35091400 | Characterization of an Italian founder mutation in the RING-finger domain of BRCA1. |
| Q73413375 | Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online |
| Q96962174 | Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q36962452 | Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences |
| Q28249078 | Chromosomal localizations and molecular analysis of TDG gene-related sequences |
| Q35447780 | Classification of BRCA1 missense variants of unknown clinical significance |
| Q60163574 | Clinical and molecular description of a Wilms tumor in a patient with tuberous sclerosis complex |
| Q57419705 | Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q61970275 | Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34394665 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction |
| Q35889575 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q24655824 | Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q33742096 | Common genetic variants and modification of penetrance of BRCA2-associated breast cancer |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q36393232 | Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers |
| Q35870067 | Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q37434133 | Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34213403 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers |
| Q34603197 | Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q28652730 | Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing |
| Q44856783 | Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium |
| Q74453751 | Concurrent Pheochromocytoma, Paraganglioma, Papillary Thyroid Carcinoma, and Desmoid Tumor: A Case Report with Analyses at the Molecular Level |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q57748258 | Constitutional ring chromosome 11 mosaicism in a Wilms tumor patient: Cytogenetic, molecular and clinico-pathological studies |
| Q57266620 | Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer |
| Q45793899 | Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer. |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q46713406 | Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases |
| Q34582442 | Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis |
| Q54480730 | Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations. |
| Q21144874 | DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q50416430 | Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1. |
| Q30717784 | Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method |
| Q69892701 | Detection of two TaqI polymorphisms in the VTR region of the human HRAS1 oncogene |
| Q34116553 | Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis |
| Q58813401 | Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation |
| Q47290195 | Different genetic features associated with colon and rectal carcinogenesis. |
| Q61970281 | Distinct breakpoints in band 11q23 of the t(4;11) and t(11;14) associated with leukocyte malignancy |
| Q35618857 | ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes |
| Q57083824 | Erratum: COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer |
| Q51016187 | Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability. |
| Q56928445 | Estrogen Receptor-Beta Expression in Hereditary Breast Cancer |
| Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
| Q35009015 | Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases |
| Q30657823 | Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines |
| Q37481884 | Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). |
| Q37745041 | Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers |
| Q34806825 | Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. |
| Q57881796 | Evidence for a link between TNFRSF11A and risk of breast cancer |
| Q34084450 | Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q58813316 | Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases |
| Q33863235 | Exploring the link between MORF4L1 and risk of breast cancer |
| Q35999309 | FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q34023407 | Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q36087170 | Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34572133 | First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report |
| Q44415170 | Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics |
| Q47713981 | Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae |
| Q33327077 | Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q64244649 | GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes |
| Q57821557 | Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of in Wilms tumour susceptibility |
| Q53467456 | Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q35022825 | Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q34190897 | Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse |
| Q40770800 | Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry |
| Q73592556 | Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis |
| Q45972889 | Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families. |
| Q54562204 | Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. |
| Q33207533 | Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14. |
| Q61970277 | Germline mutations ofAXIN2are not associated with nonsyndromic colorectal cancer |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q60432501 | HMGA1 protein expression in familial breast carcinoma patients |
| Q69913756 | HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease |
| Q42856743 | Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2 |
| Q57471595 | Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q61970280 | Homozygous intragenic loss of the WT1 locus in a sporadic intralobar wilms' tumor |
| Q68565722 | Human TRK proto-oncogene maps to chromosome 1q32-q41 |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q50416634 | Identification of a novel disease-associated variant in the BRCA1 3’UTR that introduces a functional miR-103 target site. |
| Q39321320 | Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q74335934 | Ileorectal anastomosis in patients with familial adenomatous polyposis |
| Q36603837 | Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q53345090 | Increased frequency of disease-causing MYH mutations in colon cancer families. |
| Q38610326 | Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility |
| Q37410472 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q43776684 | Integration and Expression of Mcf-13 Provirus in Mcf-13-Induced Lymphomas |
| Q35053925 | Integrative analysis of hereditary nonpolyposis colorectal cancer: the contribution of allele-specific expression and other assays to diagnostic algorithms |
| Q34081324 | Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer |
| Q28269118 | Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis |
| Q61970268 | Is WTX a suitable target for cancer therapy? |
| Q26829595 | Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop |
| Q92313654 | Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q45760446 | Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology |
| Q69426000 | Loss of heterozygosity in human germinal tumors |
| Q69894468 | Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanoma |
| Q40444169 | Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells |
| Q47795729 | Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types |
| Q31043651 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q58813482 | Mapping of a Putative Tumor Suppressor Locus to Proximal 7p in Wilms Tumors |
| Q73501756 | Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes |
| Q92860654 | Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q34988292 | Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility |
| Q61970274 | Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers |
| Q54537693 | Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q73554869 | Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition |
| Q37184717 | Misbehaviour of XIST RNA in breast cancer cells |
| Q61622980 | Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome |
| Q40995032 | Molecular genetics of hereditary non-polyposis colorectal cancer (HNPCC). |
| Q42804840 | Monoclonal antibodies against NIH 3T3 cells transformed by human thyroid carcinoma DNA. |
| Q44422800 | Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q35984974 | Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study |
| Q49024646 | Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. |
| Q36115338 | Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q54396803 | No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. |
| Q47779485 | No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome |
| Q59287240 | Non-chromosome 11-p syndromes in Wilms tumor patients: Clinical and cytogenetic report of two Down syndrome cases and one Turner syndrome case |
| Q39821454 | Nonfluorescent denaturing HPLC-based primer-extension method for allele-specific expression: application to analysis of mismatch repair genes |
| Q41507618 | Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy |
| Q38366779 | Onco-suppressor genes in human cancer |
| Q34120135 | Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis |
| Q47701078 | Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group |
| Q36280191 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q61970269 | PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer |
| Q60315437 | PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q35737888 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q35741630 | Pathology of ovarian cancers in BRCA1 and BRCA2 carriers |
| Q44044260 | Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q97524107 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q33704900 | Prediction and assessment of splicing alterations: implications for clinical testing |
| Q42481495 | Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype |
| Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q54531814 | Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas. |
| Q44785975 | Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q59238429 | Putative common origin of two MLH1 mutations in Italian-Quebec hereditary non-polyposis colorectal cancer families |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q40555797 | RFLP for TaqI of the human thyroid papillary carcinoma (PTC) oncogene |
| Q42672216 | Rare variants in XRCC2 as breast cancer susceptibility alleles |
| Q54533098 | Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. |
| Q30250038 | Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients |
| Q41681316 | Recommendations for the molecular diagnosis of familial adenomatous polyposis. |
| Q47284128 | Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis |
| Q35435822 | Recurrent germline mutation in MSH2 arises frequently de novo |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q70111753 | Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC |
| Q58813424 | Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours |
| Q44884896 | Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study |
| Q57269829 | Response: Table 1 |
| Q50498224 | Retina-derived POU domain factor 1 coordinates expression of genes relevant to renal and neuronal development. |
| Q53314159 | SNPs in ultraconserved elements and familial breast cancer risk. |
| Q40532746 | SacI identifies an additional RFLP at the D11S12 locus |
| Q71536083 | Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test |
| Q74643959 | Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation |
| Q31049299 | Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases. |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q33782791 | Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility |
| Q50186201 | Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition. |
| Q50535412 | Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. |
| Q40506809 | TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene |
| Q39504471 | Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism. |
| Q36615665 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions |
| Q45973022 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q51551407 | The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. |
| Q44955073 | The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q42995400 | The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop |
| Q34115636 | The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q42371653 | The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk |
| Q60315446 | The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians |
| Q93006972 | The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases |
| Q37401496 | The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q60487433 | The association between weight at birth and breast cancer risk revisited using Mendelian randomisation |
| Q64239462 | The association between weight at birth and breast cancer risk revisited using Mendelian randomisation |
| Q71649899 | The coatomer protein delta-COP, encoded by the archain gene, is conserved across diverse eukaryotes |
| Q24322079 | The human archain gene, ARCN1, has highly conserved homologs in rice and Drosophila |
| Q67904255 | The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31 |
| Q51999453 | The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors. |
| Q60315457 | The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases |
| Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
| Q57265670 | The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain |
| Q92952990 | Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q58556556 | Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction |
| Q40561934 | Two RFLPs generated by Taq I at the human HRAS1 locus |
| Q39544500 | Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q33522197 | Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability |
| Q60170551 | Unclassified variants in BRCA genes: guidelines for interpretation |
| Q33214171 | WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities |
| Q34586198 | Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles |
| Q40573572 | Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. |
| Q33224957 | Wilms tumor in monozygous twins: clinical, pathological, cytogenetic and molecular case report |
| Q51296900 | X chromosome inactivation pattern in BRCA gene mutation carriers. |
| Q37521015 | miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.